JZP598, GEMCITABINE , TRASTUZUMAB , CAPECITABINE , VINORELBINE , ERIBULIN
JZP598-303
Phase 3 small_molecule active
Quick answer
JZP598, GEMCITABINE , TRASTUZUMAB , CAPECITABINE , VINORELBINE , ERIBULIN for Metastatic HER2-positive breast cancer is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals Ireland Limited
- Indication
- Metastatic HER2-positive breast cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active